In recent years, gonadotropin-releasinghormone agonist (GnRHa) has become an alternative to hCG in the prevention of OHSSin PCOS patients due to the more widespread use of GnRH antagonist (GnRHa)protocols. Here, GNRH1 is linked to polycystic ovary syndrome.